KR900006555B1 - 1,2,4-oxadiazole derivatives and preparation method thereof - Google Patents
1,2,4-oxadiazole derivatives and preparation method thereof Download PDFInfo
- Publication number
- KR900006555B1 KR900006555B1 KR1019880008435A KR880008435A KR900006555B1 KR 900006555 B1 KR900006555 B1 KR 900006555B1 KR 1019880008435 A KR1019880008435 A KR 1019880008435A KR 880008435 A KR880008435 A KR 880008435A KR 900006555 B1 KR900006555 B1 KR 900006555B1
- Authority
- KR
- South Korea
- Prior art keywords
- oxadiazole
- mol
- methyl
- dichlorophenoxy
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
내용 없음.No content.
Description
본 발명은 제초제로 유용한 하기 일반식(I)의 1,2,4-옥사디아졸 유도체 및 그의 제조방법에 관한 것이다.The present invention relates to 1,2,4-oxadiazole derivatives of the general formula (I) below which are useful as herbicides and methods for their preparation.
상기식에서, R1은 디클로로페녹시메될, 벤질, 에틸, 아미도, 저급알킬아미노카르보닐, 메톡시카르보닐아미노, 저급알킬우레이도, 에톡시카르보닐알콕시, 디에틸티오카르바모일메될, 할로겐이 1개 또는 2개 치환된 알릴아미노카르보닐, 페닐을 나타대며, R2는 디클로로페녹시메틸, 히드륵시, 클로로, 디에될티오카르바모일메틸, 에톡시카르보닐알콕시제녹시메틸, 에톡시카르보닐알콕시페녹시, 디클로로페녹시, 니트로페녹시, 에톡시카르보닐, 아미도, 저급알킬아미노카르보닐, 디에틸포스포닐을 나타낸다.Wherein R 1 is dichlorophenoxymethyl, benzyl, ethyl, amido, lower alkylaminocarbonyl, methoxycarbonylamino, lower alkylureido, ethoxycarbonylalkoxy, diethylthiocarbamoylmethylyl , Allylaminocarbonyl substituted with one or two halogens, phenyl, R 2 is dichlorophenoxymethyl, hydroxy, chloro, diethylthiocarbamoylmethyl, ethoxycarbonylalkoxyalkoxyoxy , Ethoxycarbonylalkoxyphenoxy, dichlorophenoxy, nitrophenoxy, ethoxycarbonyl, amido, lower alkylaminocarbonyl and diethylphosphonyl.
1,2,4-옥사디아졸계 화합물은 1960년 이후 다양한 합성법의 개발과 아울러 생리활성에 관한 연구에 의해 수많은 화합물이 마취제, 진통게, 소염제 등과 같은 의약품으로 사용되어 오고 있다. 그외에도 섬유의 표면처리제, 염료의 중간체, 고분자 첨가제 등으로도 이용되고 있다.Since 1,600, 1,2,4-oxadiazole-based compounds have been used in medicines such as anesthetics, analgesic crabs, anti-inflammatory drugs, etc., since 1960, as well as the development of various synthetic methods and studies on physiological activity. Besides, it is also used as a surface treatment agent for fibers, intermediates for dyes, and polymer additives.
근래에, 티아졸, 티아디아졸,이소윽사졸, 피라졸 등의 헤테로환을 포함하는 유기화합물들이 농약으로 이용되면서 1,2,4-옥사디아졸계의 화합물이 살균제, 살선충제, 제초제 등으로 개발되고 있다. 특히, 제초제로서 효과가 있다고 알려진 학합물들은 공지의 제초제의 구조인 아미드, 디페닐에테르, 술포닐우레아와 같은 화합물의 측쇄에 1,2,4-옥사디아졸 구조가 치환된 학합물믈이 미합중국 특허 제3,822,280호, 독일연방공화국 공개특허 제2,801,509호, 동제2,842,248호, 동제3,122,340호, 미합중국 특허 제4,166,732호, 유럽 특허 제161,882호, 동제192,706호, 동제111,442호, 일본 특허공개 소61-63,668호 등의 명세서에 개시되어 있다. 이와같이 1,2,4-옥사디아졸계 화합물들은 제초제로서 크게 기대되고 있으며, 또한 현재도 당분야에서 계속연구 개발중에 있다.Recently, organic compounds containing heterocycles such as thiazole, thiadiazole, isoxazazole, and pyrazole are used as pesticides, and 1,2,4-oxadiazole-based compounds are used as fungicides, nematicides, herbicides, etc. Is being developed. In particular, the compounds known to be effective as herbicides are those in which 1,2,4-oxadiazole structures are substituted in the side chains of compounds such as amides, diphenyl ethers, and sulfonylureas, which are known as herbicide structures. 3,822,280, JP 2,801,509, 2,842,248, 3,122,340, US 4,166,732, 161,882, 192,706, 111,442, JP 61-63,668, etc. Disclosed in the specification. As described above, 1,2,4-oxadiazole-based compounds are greatly expected as herbicides, and are still being researched and developed in the art.
이상적인 제초제이기 위하여는 잡초의 전생장기간을 통하여 l회의 소량 사용으로서 선택적 잡초 방제 효과를 나타내어야 할 뿐 아니라, 제초제를 적용할 작물에 대하여 근본적으로 약해가 없는 비독성이어야 하고, 토양을 오염시키지 않도록 제초제 자체가 분해되거나 소산되어야 한다. 종래의 제초제들은 상기한 바와같은 이상적인 제초제로 인정하기에는 다소 문제가 있었다.To be an ideal herbicide, not only should we have selective weed control with a small amount of l use throughout the entire growing season of weeds, but it must also be non-toxic, essentially harmless to the crops to which the herbicide is applied, and not to contaminate the soil. It must itself decompose or dissipate. Conventional herbicides have been somewhat problematic to recognize as ideal herbicides as described above.
본 발명자는 전술한 결점을 해결하고자 광범위하게 연구 검토한 결과,1,2,4-옥사디아졸계의 신규 화합물들이 잡초에 대하여 강력한 제초활성을 나타대며, 작물과 잡초 사이의 고도의 선택성을 갖는 것을 발견하고 본 발명을 완성하게 되었다. 즉, 상기 일반식(I)화합물들은 논토양에 생장하는 일년생 잡초에 대하여 250g//ha 이하의 농도에서 제초효과가 양호 내지 우수할 뿐만아니라 방제가 어려운 다년생 잡초에 대해서도 500g/ha의 농도로서 우수한 제초효과를 나타낸다. 반면에 벼에 대해서는 대단히 안전하다. 또한 밭토양에 생장하는 광엽잡초에 대해서도 방제효과가 우수하며 화본과의 옥수수, 밀 등에 안전하여 고도의 선택성을갖고 있다.The present inventors have conducted extensive research to solve the above-mentioned shortcomings. As a result, new compounds of 1,2,4-oxadiazole series exhibit strong herbicidal activity against weeds and have a high selectivity between crops and weeds. Discovered and completed the present invention. That is, the compounds of general formula (I) have good or superior herbicidal effect at concentrations of 250 g // ha or less for annual weeds growing in paddy soils, and excellent concentrations of 500 g / ha for perennial weeds that are difficult to control. Herbicidal effect. On the other hand, it is very safe for rice. In addition, it has excellent control effect against broadleaf weeds growing in the field soil and is highly selective because it is safe to corn and wheat with flower.
본 발명의 제1목적은 상기 일반식(I)의 1,2,4-옥사디아졸 유도체를 제공하는데 있다.It is a first object of the present invention to provide 1,2,4-oxadiazole derivatives of the general formula (I).
본 발명의 제2목적은 상기 일반식(I)의 1,2,4-옥사디아졸 유도체의 제조방법을 제공하는 것이다.A second object of the present invention is to provide a method for preparing the 1,2,4-oxadiazole derivatives of the general formula (I).
본 발명의 제3목적은 상기 일단식(I)의 l,2,4-옥사디아졸 유도체로 부터 선택된 1종 이상을 유효성분으로 함유하는 것을 특징으로 하는 제초제로서의 용도를 제공하는 것이다.It is a third object of the present invention to provide a use as a herbicide, characterized in that it contains at least one selected from l, 2,4-oxadiazole derivatives of the above formula (I) as an active ingredient.
이하 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 일반식(I) 화합물은 다음의 방법들에 따라 제조될 수 있다. 그러나, 본 발명이 이들 방법에 한정되지 아니함은 당연하다.Formula (I) compounds of the present invention can be prepared according to the following methods. However, it is obvious that the present invention is not limited to these methods.
(제 1 방법)(First method)
[1공정][Step 1]
일반식(Ⅱ)의 할라이드를 용매 및 촉매존재하에 일반식(III)의 시안화물과 반응시켜 일반식(IV)의 니트릴을 제조한다 이 반응에서 아실클로라이드, 알킬클로로포름에이트 등을 사용하며, 용매로는 할로겐화 탄화수소, 에테르 등이 적당하며, 촉매는 상전이 촉매로서 트리카프릴메틸암모늄클로라이드(이하 "알리트트336"이라 칭함), 18-크라운-6-에테르, 벤질트리에틸암모늄클로라이드와 같은 4급 암모늄염이 바람직하다. 또한 이 반응에 소량의 물을 사용하는 것이 좋으며, 사용량은 용매에 대해 0.1-0.2%(부피)가 바람직하다. 반응온도는 용매의 비등점으로서 30-50℃의 온도가 적당하다.A nitrile of formula (IV) is prepared by reacting a halide of formula (II) with a cyanide of formula (III) in the presence of a solvent and a catalyst. In this reaction, acyl chloride, alkylchloroformate, and the like are used. Is suitable for halogenated hydrocarbons, ethers, etc., and the catalyst is a tricaprylmethylammonium chloride (hereinafter referred to as "allite) as a phase transfer catalyst. Quaternary ammonium salts, such as 336 "), 18-crown-6-ether and benzyltriethylammonium chloride, are also preferred. A small amount of water is preferred for this reaction and the amount used is 0.1-0.2 for the solvent. % (Volume) is preferred The reaction temperature is preferably 30-50 ° C. as the boiling point of the solvent.
[2공정][2 steps]
1공정에서 얻은 일단식(IV)의 니트릴을 용매중 실온 내지 60℃에서 일반식(V)의 황화수소와 반응시켜 일반식(VI)의 티오카르바모일 유도체를 얻는다. 이때 황화수소는 반드시 건조시켜 사용하는 겻이 바람직하다. 용매로서는 벤젠, 톨루엔, 에테르, 석유에테르, 헥산 등이 적당하며, 반응온도는 실온 내지 60℃의 범위가 바람직하다. 촉매로는 디에틸아민이나 트리에틸아민과 같은 염기를 사용하면 더욱 바람직하다.The nitrile of formula (IV) obtained in step 1 is reacted with hydrogen sulfide of formula (V) at room temperature to 60 캜 in a solvent to obtain a thiocarbamoyl derivative of formula (VI). At this time, hydrogen sulfide is preferably dried and used. As the solvent, benzene, toluene, ether, petroleum ether, hexane and the like are suitable, and the reaction temperature is preferably in the range of room temperature to 60 ° C. It is more preferable to use a base such as diethylamine or triethylamine as the catalyst.
[3공정][3 step]
2공정에서 얻은 일반식(VI)을 염기 및 촉매존재하에 일반식(VII)의 히드록살아민가 반응시켜 일반식(VIII)의 아미드옥심을 제조한다. 염기로서는 나트륨메톡사이드, 나트륨에톡사이드, 탄산칼륨, 탄산나트륨을 들 수 있으며, 용매로서는 저급알킬의 알코올을 들 수 있다.The amide oxime of the general formula (VIII) is prepared by reacting the general formula (VI) obtained in step 2 with the presence of a base and a catalyst. Examples of the base include sodium methoxide, sodium ethoxide, potassium carbonate and sodium carbonate, and examples of the solvent include lower alkyl alcohols.
[4공정][4 steps]
3공정에서 제조한 일반식(VIII)의 아미드옥심과 일반식(IX)의 아실킬로라이드를 유기염기 또는 무기염기 존재하에서 건조된 아세톤, 아세트니트릴, 톨루엔, 에틸아세테이트, 할로겐화 탄화수소, 디옥산, 에테르 등의 선택된 용매 중 반응시켜 일단식(X)의 0-아실아미드옥심을 제조한다. 상기에서 유기염기로는 트리에틸아민, 피리딘 등을 들 수 있으며, 무기염기로는 탄산나트륨, 단산칼륨 등을 들 수 있다.The amide oxime of formula (VIII) and the acyl chloride of formula (IX) prepared in step 3 were dried with acetone, acetonitrile, toluene, ethyl acetate, halogenated hydrocarbon, dioxane, ether in the presence of organic or inorganic base. Reaction in a selected solvent such as to prepare a 0-acylamide oxime of formula (X). Examples of the organic base include triethylamine, pyridine, and the like, and examples of the inorganic base include sodium carbonate and potassium monocarbonate.
반응온도는 유기염기 사용시 상온 내지 60℃가 바람직하며, 무기염기 사용시에는 용매의 비등점의 온도가 바람직하다.The reaction temperature is preferably from room temperature to 60 ℃ when using an organic base, the temperature of the boiling point of the solvent is preferred when using an inorganic base.
[5공정][5 steps]
4공정에서 얻은 일반식(X)의 0-아실아이드옥심을 촉매존재하 유기용매 중에서 폐환 반응시켜 목적하는 일반식(Ia)의 1,2,4-옥사이다졸 유도체를 제조한다. 이때 사용되는 촉매로는 나트륨메톡사이드, 디에틸아민, 트리에틸아민, 트리플루오르붕소에테르(BF3·Et2O)등을 사용할 수 있으며, 용매로서는 아세톤, 알코올, 디옥산, 톨루엔 등이 바람직하다. 반응온도는 사용되는 용매의 비등점이 적당하며 반응시간은 4 내지 12시간이 바람직하다.The 1,2-4-oxadiazole derivatives of the general formula (Ia) are prepared by subjecting the 0-acylamide oxime of the general formula (X) obtained in step 4 to ring closure in an organic solvent in the presence of a catalyst. At this time, as the catalyst, sodium methoxide, diethylamine, triethylamine, trifluoroboron ether (BF 3 · Et 2 O) and the like can be used, and acetone, alcohol, dioxane, toluene and the like are preferable. . The reaction temperature is suitable for the boiling point of the solvent used, the reaction time is preferably 4 to 12 hours.
상기 방법을 반응식으로 나타내며 다음과 같다,The method is represented by the reaction scheme as follows.
상기식에서, R1은 전술한 바와 같으며, M은 나트륨, 칼륨 또는 구리를 나타낸다.Wherein R 1 is as defined above and M represents sodium, potassium or copper.
(제 2 방법)(Second method)
[1공정][Step 1]
일반식(IV) 니트릴과 일반식(VII)의 히드록실아민의 염산염이나 황산염 또는 이를 알칼리로 중화시켜 얻은 유리히드록실아민을 당량비로 반응시켜 일반식(VIII)의 아미드옥심을 얻는다. 이때 사용되는 용매로는 알코올, 물 등이 바람직하며, 이들을 단독 또는 2종 이상 조합하여 사용하여도 좋다. 반응온도는 실온 내지 100℃가 바람직하다.The amide oxime of general formula (VIII) is obtained by reacting nitrile of general formula (IV) with a hydrochloride or sulfate salt of hydroxylamine of general formula (VII) or free hydroxylamine obtained by neutralizing it with alkali. At this time, as a solvent used, alcohol, water, etc. are preferable, You may use these individually or in combination of 2 or more types. The reaction temperature is preferably from room temperature to 100 ° C.
[2공정][2 steps]
일반식(VIII)의 아미드옥심과 일반식(XI)의 아실클로라이드를 반응시켜 일반식(XII)의 0-아실아미드옥심을 제조한후, 이를 폐환시켜 일반식(XIII)의 l,2,4-옥사디아졸 유도체를 얻는다. 이때 반응조건은 제1방법의 4-5공정의 조건과 동일하다. 폐환반응에서 촉매로서 트리플루오로붕소에테르(BF3·Et2O)를 사용하는 것이 바람직하다.By reacting the amide oxime of general formula (VIII) with the acyl chloride of general formula (XI) to prepare 0-acylamide oxime of general formula (XII), and ring-closing it, l, 2,4 of general formula (XIII) Obtain an oxadiazole derivative. At this time, the reaction conditions are the same as the conditions of step 4-5 of the first method. It is preferable to use trifluoroboron ether (BF 3 · Et 2 O) as a catalyst in the ring closure reaction.
[3공정][3 step]
일반식(XIII)의 "l,2,4-옥사디아졸과 일반식(XIV)의 페놀과 무기염기 존재하에서 건조된 아세톤용매중 반응시켜 일단식(Ib)의 또다른 l,2,4-옥사디아졸 유도체를 얻는다. 상기에서 무기염기로는 탄산칼륨, 탄산나트륨을 들 수 있다. 반응온도는 용매의 비등점의 온도가 바람직하다.Another l, 2,4- of formula (Ib) was reacted by reacting " l, 2,4-oxadiazole of formula (XIII) with acetone solvent dried in the presence of an inorganic base with phenol of formula (XIV). An oxadiazole derivative is obtained, in which the inorganic bases include potassium carbonate and sodium carbonate, and the reaction temperature is preferably the temperature of the boiling point of the solvent.
상기방법을 반응식으로 나타대면 다음과 같다.The above method is represented by the following reaction scheme.
상기식에서, R1는 전술한 바와 같으며, R은 치환기가 붙은 페닐을 나타낸다.Wherein R 1 is as defined above and R represents phenyl with a substituent.
(제 3 방법)(Third method)
[1공정][Step 1]
일반식(XV)의 디에틸아민과 일반식(XVI)의 카르보닐설파이드 개스를 낮은 온도에서 반응시킨후 이 용액과 일반식(XIII)의 1,2,4-옥사디아졸과 반응시켜 또다른 일반식(Ic)의 1,2,4-옥사디아졸 유도체를 얻는다. 용매로는 톨루엔이 바람직하다.The reaction of diethylamine of formula (XV) with carbonylsulfide gas of formula (XVI) at low temperature is followed by reaction of this solution with 1,2,4-oxadiazole of formula (XIII). 1,2,4-oxadiazole derivatives of the general formula (Ic) are obtained. Toluene is preferable as a solvent.
반응조건은 70℃로 가온하여 3시간동안 교반함이 바람직하다.The reaction conditions are preferably warmed to 70 ℃ and stirred for 3 hours.
상기 방법을 반응식으로 나타대면 다음과 같다.The method is represented by the following scheme.
상기식에서, R1은 전술한 바와같다.In the above formula, R 1 is as described above.
(제 4 방법)(Fourth method)
[1공정][Step 1]
일반식(VIII)과 일반식(XVII)의 에틸클로로폼름에이트를 반응시켜 일반식(XVII)의 0-아실아미드옥심을 제조한후, 이를 폐환시켜 일단식(XIX)의 1,2,4-옥사디아졸 유도체를 얻는다. 이때 반응조건은 제1방법의 4-5공정과 동일하다. 폐환반응에서 2% 수산화나트륨 수용액을 사용하는 것이 바람직하다.0-acylamide oxime of general formula (XVII) was prepared by reacting ethylchloroformemate of general formula (VIII) with general formula (XVII), and then ring-closed to give 1,2,4- of formula (XIX). Obtain an oxadiazole derivative. At this time, the reaction conditions are the same as in the step 4-5 of the first method. It is preferable to use 2% aqueous sodium hydroxide solution in the ring-closure reaction.
[2공정][2 steps]
일반식(XIX)의 1,2,4-옥사디아졸 유도체와 일단식(XX)의 포스포로스옥시트리클로라이드를 유기염기 촉매하에서 반응시켜 일반식(XXI)의 l,2,4-옥사디아졸 유도체를 얻는다. 이때 사용되는 유기염기로는 피리딘, 트리에틸아민이 바람직하다.1,2,4-oxadiazole derivatives of formula (XIX) and phosphorous oxytrichloride of formula (XX) are reacted under an organic base catalyst to form l, 2,4-oxadiazole of formula (XXI). Obtain a derivative. As the organic base used at this time, pyridine and triethylamine are preferable.
반응온도는 용매의 비등점 온도가 바람직하다.The reaction temperature is preferably the boiling point temperature of the solvent.
[3공정][3 step]
일반식(XXI)의 1,2,4-윽사디아졸 유도체와 일반식(XIV)의 페놀과 무기염기 존재하에 단응시켜 일반식(Id)의 1,2,4-옥사디아졸 유도체를 얻는다. 이때 사용되는 무기염기로는 단산칼륨이 바람직하며 용매는 아세톤이 바람직하다.1,2,4-oxadiazole derivatives of the general formula (XXI) and phenol of the general formula (XIV) are reacted in the presence of an inorganic base to obtain 1,2,4-oxadiazole derivatives of the general formula (Id). At this time, potassium inorganic acid is preferable as the inorganic base, and acetone is preferable as the solvent.
반응온도는 용매의 비등점 온도가 바람직하다.The reaction temperature is preferably the boiling point temperature of the solvent.
상기 방법을 반응식으로 나타내면 다음과 같다.The method is represented by the following scheme.
상기식에서, R1는 전술한 바와 같으며, R은 치환기가 붙은 페닐을 나타낸다.Wherein R 1 is as defined above and R represents phenyl with a substituent.
(제 5 방법)(5th method)
[1공정][Step 1]
일반식(VIII)의 아미드옥심과 일반식(XXII)의 에틸옥살릴크롤라이드를 반응시켜 일반식(XXIII)의 0-아실아미드옥심을 제조한후, 이를 폐환시켜 일반식(XXIV)의 1, 2, 4-옥사디아졸 유도체를 얻는다. 이때 반응조건은 제1방법의 4-5공정의 조건과 동일하다. 폐환반응에서 피리딘 또는 트리에틸아민을 사용하는 것이 바람직하다.0-acylamide oxime of general formula (XXIII) was prepared by reacting amide oxime of general formula (VIII) with ethyl oxalyl crolide of general formula (XXII), and then ring-opened to obtain 1, Obtain 2, 4-oxadiazole derivatives. At this time, the reaction conditions are the same as the conditions of step 4-5 of the first method. Preference is given to using pyridine or triethylamine in the ring closure reaction.
[2공정][2 steps]
일반식(XXIV)의 1, 2, 4-옥사디아졸 유도체와 일반식(XXV)의 아민을 반응시켜 일반식(Ie)의 또다른 1, 2, 4-옥사디아졸 유도체를 얻는다. 이때 사용되는 용매로는 무수에틸알코올이 바람직하다.Another 1, 2, 4-oxadiazole derivative of formula (Ie) is obtained by reacting a 1, 2, 4-oxadiazole derivative of formula (XXIV) with an amine of formula (XXV). As the solvent used at this time, anhydrous ethyl alcohol is preferable.
반응온도는 0℃가 바람직하다.The reaction temperature is preferably 0 ° C.
상기 방법을 반응식으로 나타내면 다음과 같다.The method is represented by the following scheme.
상기식에서, R1는 전술한 바와 같으며, R2,R3는 수소, 알킬, 알릴, 알콕시 등을 나타낸다.Wherein R 1 is as defined above and R 2 , R 3 represent hydrogen, alkyl, allyl, alkoxy and the like.
상기 제1-5방법에 있어서, 각 공정별로 얻어지는 니트릴, 아미드옥심, 0-아실아미드옥심 및 최종 생성물인 1,2,4-옥사디아졸 유도체는 각 화합올의 물성에 따라 증류, 결정화, 크로마토그라피와 같은 당분야에서 통상적으로 수행되어지는 방법에 따라 분리, 정제하였으며 화합물의 동정은 IR, NMR, 질량분석기 등을 사용하여 수행했다.In the above 1-5 method, the nitrile, amide oxime, 0-acylamide oxime and final product 1,2,4-oxadiazole derivatives obtained by each step are distilled, crystallized and chromatized according to the physical properties of each compound. Isolation and purification were carried out according to methods commonly performed in the art, such as graphiography, and the identification of compounds was carried out using IR, NMR, mass spectrometry, and the like.
다음 실시예로서 본 발명을 더욱 구체적으로 설명한다.The present invention is explained in more detail by the following examples.
[실시예 1]Example 1
(1) 에틸시아노포름에이트의 합성(1) Synthesis of Ethyl Cyanoformate
메틸렌클로라이드 250ml에 시안화나트륨 24.5g(0.5몰)과 물 2.5ml(용매양의 1-2%)와 알리트 336 2ml를 넣고 교반하면서 에틸클로로포름에이트 54.2g(0.5몰)을 서서히 적가하였다. 완전히 적가한후 2-3시간 가량 환류하여 생성된 염화나트륨을 여과하였다. 여액을 상압 증류하여 112-116℃에서 액체인 에틸시아노포름에이트 28.4g을 얻었다.(수율 58.6%)250 ml of methylene chloride, 24.5 g (0.5 mol) of sodium cyanide, 2.5 ml of water (1-2% of solvent) and ali 54 ml of ethyl chloroformate (0.5 mol) was slowly added dropwise with 2 ml of Tetra 336. After complete dropwise addition, the resulting sodium chloride was filtered by refluxing for 2-3 hours. The filtrate was atmospheric distilled to give 28.4 g of ethylcyanoformate as a liquid at 112-116 ° C. (Yield 58.6%)
NMR(CDCl3,TMS)δ ; 4.75-4.30(q,2H), 1.55-1.30(t,3H).NMR (CDCl 3 , TMS) δ; 4.75-4.30 (q, 2H), 1.55-1.30 (t, 3H).
(2) 에필티오옥사메이트의 합성(2) Synthesis of Epithioxamate
벤젠 70ml에 에틸시아노포름에이트 25g(0.25몰)을 넣고 0℃를 유지하면서 황화수소 개스를 통과시켜 포화시켰다. 이 용액에 트리에틸아민을 1ml 넣고 다시 황화수소 개스를 주입시켜 35℃까지 상승했던 온도가15-20℃로 하강할때까지 반응시켰다. 24시간 방치시켜 노란색의 침상결정을 얻었다. 벤젠에서 재결정하여 융점 65℃의 황색 결정을 23g얻었다.(수율 69.1%)25 g (0.25 mole) of ethyl cyanoformate was added to 70 ml of benzene, and the mixture was saturated by passing hydrogen sulfide gas while maintaining 0 ° C. 1 ml of triethylamine was added to this solution, and hydrogen sulfide gas was added again, and it reacted until the temperature which rose to 35 degreeC fell to 15-20 degreeC. It was left for 24 hours to obtain yellow needles. Recrystallization from benzene yielded 23 g of yellow crystals having a melting point of 65 DEG C. (yield 69.1%).
(3) 에톡시카르보닐포름아미드옥심의 합성(3) Synthesis of ethoxycarbonylformamide oxime
에틸알코올 100ml에 탄산나트륩 2.3g(0.1몰)을 용해시킨 용액에 히드록실아민염산염 6.95g(0.1몰)을 에틸알코올 150ml에 용해시켜 가하였다. 생성된 염화나트륨을 여과한 용액에 (2)에서 제조한 에틸티오옥사메이트 13.3g(0.1몰)을 가하여 1시간 교반한후 24시간 방치하였다. 용매를 감압 농축하여 생성된 백색결정을 에테르로 세척한후 감압 건조하였다. 융점 10l℃의 백색결정인 에톡시카르보닐포름아이드옥심 12.05g을 얻었다.(수율 91.3%)6.95 g (0.1 mol) of hydroxylamine hydrochloride was added to 150 ml of ethyl alcohol in a solution of 2.3 g (0.1 mol) of sodium carbonate in 100 ml of ethyl alcohol. 13.3 g (0.1 mol) of ethylthiooxamate prepared in (2) was added to the filtered solution of sodium chloride, which was stirred for 1 hour and left for 24 hours. The solvent was concentrated under reduced pressure, and the resulting white crystals were washed with ether and dried under reduced pressure. 12.05 g of ethoxycarbonylformamide oxime was obtained as a white crystal having a melting point of 10 lC. (Yield 91.3%)
(4) 3-에톡시카르보닐-5-(2',4'-디클로로페녹시) 메틸-1,2,4-옥사디아졸의 합성(4) Synthesis of 3-ethoxycarbonyl-5- (2 ', 4'-dichlorophenoxy) methyl-1,2,4-oxadiazole
(3)에서 제조한 에톡시카르보닐포름아미드옥심 6.6g(0.05몰)과 2,4-디클로로페녹시아세틸클로라이드 11.9g(0.05몰)을 디옥산 l50ml와 혼합한후, 트리플로오르붕소·에데르 0.71g(0.005몰)을 첨가하여 4시간 가열 환류시켰다. 반응한 농축액을 컬럼크로마트그라피(용리제, 벤젠 : 에테르=1 : 1)로 정제하여 융점 94℃의 무색절정 10.6을 얻었다.(수율 66.8%)After mixing 6.6 g (0.05 mole) of ethoxycarbonylformamide oxime and 11.9 g (0.05 mole) of 2,4-dichlorophenoxyacetyl chloride prepared in (3) with l50 ml of dioxane, trifluoroorborate Der 0.71 g (0.005 mol) was added and heated to reflux for 4 hours. The reaction solution was purified by column chromatography (eluent, benzene: ether = 1: 1) to give a colorless peak of 10.6 with a melting point of 94 ° C. (Yield 66.8%)
NMR(CDC13,TMS)δ ; 7.30-6.80(m, 3H), 5.30(s, 2H), 4.65-4.30(q, 2H), 3.05(s, 6H)NMR (CDC1 3, TMS) δ; 7.30-6.80 (m, 3H), 5.30 (s, 2H), 4.65-4.30 (q, 2H), 3.05 (s, 6H)
(5) 3-N, N-디메틸아미노카르보닐-5-(2',4'-디클로로페녹시)메틸-1,2,4-옥사디아졸의 합성 무수에틸알코올 50m1에 (4)에서 합성한 화합물 0.5g(l.58몰)을 넣고 0℃에서 교반시키면서 디메틸아민개스를 주입시켰다. 생성된 고체를 여과하여 융점 114-115℃의 백색고체 0.4g을 얻었다.(수율 80.3%)(5) Synthesis of 3-N, N-dimethylaminocarbonyl-5- (2 ', 4'-dichlorophenoxy) methyl-1,2,4-oxadiazole Synthesis in 50m1 of anhydrous ethyl alcohol in (4) 0.5 g (1.58 mol) of one compound was added thereto, and dimethylamine gas was injected with stirring at 0 ° C. The resulting solid was filtered to yield 0.4 g of a white solid having a melting point of 114-115 占 폚 (yield 80.3%).
원소분석(C12H11C12N3O3)Elemental Analysis (C12H11C1 2 N 3 O 3 )
이론치 : C ; 45.59, H ; 3.5l, N ; 13.29.Theoretic value: C; 45.59, H; 3.5l, N; 13.29.
실측치 : C ; 45.64, H ; 3.48, N ; 13.32.Found: C; 45.64, H; 3.48, N; 13.32.
NMR(아세톤 d6,TMS)δ; 7.60-7.30(m, 3H), 5.65(s, 2H), 3.05(s, 6H)NMR (acetone d 6 , TMS) δ; 7.60-7.30 (m, 3H), 5.65 (s, 2H), 3.05 (s, 6H)
[실시예 2-6]Example 2-6
각각의 치환된 아민으로부터 실시예 1의 방법을 사용하여 제조하였다. 각 화합물들은 모두 컬럼크로마토그라피로 정제하였으며 물성 및 원소분석치는 표 1과 같다.Prepared using the method of Example 1 from each substituted amine. Each compound was purified by column chromatography and the physical and elemental analysis values are shown in Table 1.
[실시예 7]Example 7
(1) 3-히드라지도-5-(2',4'-디클로로페녹시)메틸-1,2,4-옥사디아졸의 합성.(1) Synthesis of 3-hydrazido-5- (2 ', 4'-dichlorophenoxy) methyl-1,2,4-oxadiazole.
실시예 1의 (4)에서 합성한 3-에톡시카르보닐-5-(2',4'-디클로로페녹시)메틸-1,2,4-옥사디아졸 6.34g(0.02몰)을 에틸알코올 150ml에 혼합하여 교반하면서 히드라진 수화물 3.4ml를 15℃로 유지하며 서서히 적가하였다. 반응액을 0℃에서 30분 반응시킨후 생성된 고체를 여과하여 에틸알고올 10ml로 세척하였다. 생성물을 건조하여 융점 105℃의 백색결정 4.2g을 얻었다.(수율 69.3%)6.34 g (0.02 mol) of 3-ethoxycarbonyl-5- (2 ', 4'-dichlorophenoxy) methyl-1,2,4-oxadiazole synthesized in Example 4 (4) was ethyl alcohol. 3.4 ml of hydrazine hydrate was slowly added dropwise while maintaining the mixture at 150 ml while stirring at 15 ° C. The reaction solution was reacted at 0 ° C. for 30 minutes, and the resulting solid was filtered and washed with 10 ml of ethyl alcohol. The product was dried to give 4.2 g of white crystals having a melting point of 105 캜. (Yield 69.3%)
NMR(DMSO-d6,TMS)δ; 7.45-7.10(m, 3H), 6.30-5.90(b, 3H), 5.50(s, 2H)NMR (DMSO-d 6 , TMS) δ; 7.45-7.10 (m, 3H), 6.30-5.90 (b, 3H), 5.50 (s, 2H)
(2) 3-아지도-5-(2',4'-디클로로페녹시)메틸-1,2,4-옥사디아졸의 합성.(2) Synthesis of 3-azido-5- (2 ', 4'-dichlorophenoxy) methyl-1,2,4-oxadiazole.
3-히드라지도-5-('2,4'-디콜로로페녹시)메틸-1,2,4-옥사디아졸 3.33g(0.11몰)을 진한 염산 35ml와 빙초산 14.5ml를 혼합하여 교반하였다. 반응온도를 0℃이하로 유지시키며 아질산나트륨 1.89g을 물 5.3ml에 녹인 용액을 40분에 걸쳐 서서히 적가하였다. 반응액을 2시간동안 암흑 상태에서 방치한후 물 100ml와 혼합하고 클로로포름 50ml로 추출하여 유기층으로부터 융점 103-104℃의 백색결정연 생성물 2.43g을 얻었다.(수율 70.4%)3.33 g (0.11 mol) of 3-hydrazido-5-('2,4'-dicolophenoxy) methyl-1,2,4-oxadiazole was stirred by mixing 35 ml of concentrated hydrochloric acid and 14.5 ml of glacial acetic acid. . The reaction temperature was kept below 0 ° C. and a solution of 1.89 g of sodium nitrite dissolved in 5.3 ml of water was slowly added dropwise over 40 minutes. The reaction solution was left in dark for 2 hours, mixed with 100 ml of water and extracted with 50 ml of chloroform to obtain 2.43 g of white crystal lead product having a melting point of 103-104 ° C. from the organic layer. (Yield 70.4%)
NMR(CDC13, TMS)δ ; 7.45-7.15(m, 3H), 5.25(s, 2H)NMR (CDC1 3 , TMS) δ; 7.45-7.15 (m, 3H), 5.25 (s, 2H)
(3) 3-메톡시카르보닐아미노-5-(2',4'-디클로로페녹시)메틸-1,2,4-옥사디아졸의 합성.(3) Synthesis of 3-methoxycarbonylamino-5- (2 ', 4'-dichlorophenoxy) methyl-1,2,4-oxadiazole.
3-아지드-5-(2',4'-디클로로페녹시)메틸-1,2,4-옥사디아졸 1.5g(0.0048몰)과 메틸알코올 0.32g(0.01몰)을 디옥산 20ml에 혼합하여 1시간 교반 환류시킨후, 용매를 제거시켜 얻은 생성물을 용매(헥산 : 에틸아세테이트=2 : l)에서 재결정하여 융점 90-91℃의 백색고체 1.2g을 얻었다.(수율 82.8%)Mix 1.5 g (0.0048 mol) of 3-azide-5- (2 ', 4'-dichlorophenoxy) methyl-1,2,4-oxadiazole and 0.32 g (0.01 mol) of methyl alcohol in 20 ml of dioxane After refluxing for 1 hour, the solvent was removed and the product obtained was recrystallized in a solvent (hexane: ethyl acetate = 2: l) to obtain 1.2 g of a white solid having a melting point of 90-91 ° C. (Yield 82.8%)
원소분석(C11H9Cl2N3O4)Elemental Analysis (C 11 H 9 Cl 2 N 3 O 4 )
이론치 : C ; 41.53, H ; 2.85, N ; 13.21Theoretic value: C; 41.53, H; 2.85, N; 13.21
실측치 : C ; 41.47, H ; 2.90, N ; 13.23Found: C; 41.47, H; 2.90, N; 13.23
NMR(아세톤d6,TMS) δ; 7.70-7.60(b, 1H), 7.60-7.20(m, 3H), 5.65(s, 2H), 4.01(s, 3H)NMR (acetone d 6 , TMS) δ; 7.70-7.60 (b, 1H), 7.60-7.20 (m, 3H), 5.65 (s, 2H), 4.01 (s, 3H)
[실시예 8]Example 8
3-N, N-디에틸우레이도-5-(2',4'-디클로로페녹시)메틸-1,2,4-옥사디아졸의 합성.Synthesis of 3-N, N-diethylureido-5- (2 ', 4'-dichlorophenoxy) methyl-1,2,4-oxadiazole.
건조된 디옥산 20ml에 3-아지도-50(2',4'-디클로로페녹시)메틸-1,2,4-옥사디아졸 1.57g(0.005몰)을 가하고 질소하에서 가열교반하여 100℃에서 30분간 반응시켰다. 반응액에 디메틸아민 0.25g(0.0055몰)을 주입시키고 1일밤 교반하었다. 반응액 중에 생성된 결정을 여과하여 올로 세척한후 아세톤 100ml와 혼합하여 가열하였다. 불용성 물질을 제거한후에 용액을 감압건조시켜 융점 93-94℃의 무색 결정인 3-N, N-디에틸우레이도-5-(2',4'-디클로로페녹시)메틸-1,2,4-옥사디아졸 0.9g을 얻었다.(수율 55%)1.57 g (0.005 mol) of 3-azido-50 (2 ', 4'-dichlorophenoxy) methyl-1,2,4-oxadiazole was added to 20 ml of dried dioxane, and the mixture was heated and stirred under nitrogen at 100 ° C. The reaction was carried out for 30 minutes. 0.25 g (0.0055 mol) of dimethylamine was injected into the reaction solution, and the mixture was stirred overnight. The crystals formed in the reaction solution were filtered and washed with Ole and mixed with 100 ml of acetone and heated. After removing the insoluble substance, the solution was dried under reduced pressure to give 3-N, N-diethylureido-5- (2 ', 4'-dichlorophenoxy) methyl-1,2,4 as colorless crystals having a melting point of 93-94 占 폚. 0.9 g of oxadiazole was obtained (yield 55%).
원소분석(C12H12C12N.O3)Elemental Analysis (C 12 H 12 C1 2 NO 3 )
이론치 : C ; 43.54, H ; 3.65, N ;16.92Theoretic value: C; 43.54, H; 3.65, N; 16.92
실측치 : C ; 43.55, H ; 3.69, N ; 16.90Found: C; 43.55, H; 3.69, N; 16.90
NMR(DMSO-d8+아세톤 d6,TMS)δ ; 9.60(b, 1H), 7.60-7.20(m,3H), 5.50(s, 2H), 2.90(s, 6H)NMR (DMSOd 8 + acetone d 6 , TMS) δ; 9.60 (b, 1H), 7.60-7.20 (m, 3H), 5.50 (s, 2H), 2.90 (s, 6H)
[실시예 9]Example 9
(1) 2,4-디클로로페녹시아세트니트릴의 합성.(1) Synthesis of 2,4-dichlorophenoxyacetnitrile.
아세톤 250ml에 2,4-디클로로페놀 32.6g(0.2몰)과 탄산칼륨 27.6g(0.2몰)과 클로로아세트니트릴 l5.lg(0.2몰)을 혼합하여 4시간 교단 환류시켰다. 용매를 제거한후, 에틸아세테이트로 추출하여 생성물 34.5g을 얻었다.(수율 85.3%)To 250 ml of acetone, 32.6 g (0.2 mol) of 2,4-dichlorophenol, 27.6 g (0.2 mol) of potassium carbonate, and 5.25 (0.2 mol) of chloroacenitrile were mixed and refluxed for 4 hours. After the solvent was removed, the product was extracted with ethyl acetate to obtain 34.5 g of a product. (Yield 85.3%)
(2) 2,4-디클로로페녹시아세트아미드옥심의 합성.(2) Synthesis of 2,4-dichlorophenoxyacetamide oxime.
히드록실아민 염산염 14g(0.2몰)과 중탄산나트륨 17g(0.2몰)을 물 70ml에 녹인후 (1)에서 합성한 2,4-디클로로페녹시아세트니트릴 34.5g(0.17몰)을 에틸알코올 50ml에 녹여 적가하였다. 4-5시간 교단환류시킨후 용매를 제거하고 농축액을 용매(헥산 : 에틸아세테이트=1 : 1)에서 재결정하여 흰색이 고체 14.0g을 얻었다.(수율 37.5%)Dissolve 14 g (0.2 mol) of hydroxylamine hydrochloride and 17 g (0.2 mol) of sodium bicarbonate in 70 ml of water, and then dissolve 34.5 g (0.17 mol) of 2,4-dichlorophenoxysetnitrile synthesized in (1) in 50 ml of ethyl alcohol. Added dropwise. After refluxing for 4-5 hours, the solvent was removed, and the concentrate was recrystallized from a solvent (hexane: ethyl acetate = 1: 1) to give 14.0 g of a white solid (yield 37.5%).
(3) 3-(2',4'-디클로로페녹시) 메틸-5-에톡시카르보닐-1,2,4-옥사디아출의 합성.(3) Synthesis of 3- (2 ', 4'-dichlorophenoxy) methyl-5-ethoxycarbonyl-1,2,4-oxadiaol.
클로로포름 70ml에 2,4-디클로로페녹시메틸아미드옥심 4.69g(0.02올)과 피리딘 1.58g(0.02몰)과 에틸옥살릴클로라이드 2.72g(0.02몰)을 넣고 6시간 교반 환류하였다. 용매를 제거한후 컬럼크로마토그라피(용리제, 헥산 : 에틸아세테이트=2 : 1)로 정제하여 융점이 73-74℃연 백색고체 4.9g을 얻었다.(수율 77.4%)To 70 ml of chloroform, 4.69 g (0.02 mol) of 2,4-dichlorophenoxymethylamide oxime, 1.58 g (0.02 mol) of pyridine, and 2.72 g (0.02 mol) of ethyl oxalyl chloride were added and refluxed under stirring for 6 hours. After removing the solvent, the residue was purified by column chromatography (eluent, hexane: ethyl acetate = 2: 1) to obtain 4.9 g of a white solid at 73-74 ° C. (Yield 77.4%)
원소분석(C12H10C12N2O4)Elemental Analysis (C 12 H 10 C1 2 N 2 O 4 )
이론치 : C ; 45.45, H ; 3.18, N ; 8.83Theoretic value: C; 45.45, H; 3.18, N; 8.83
실측치 : C ; 45.38, H ; 3.22, N ; 8.79Found: C; 45.38, H; 3.22, N; 8.79
NMR(아세톤 d6, TMS)δ ; 7.45-7.20(m, 3H), 5.45(s, 2H), 4.70-4.20(q, 2H), 1.65-1.30(t, 3H).NMR (acetone d6, TMS) δ; 7.45-7.20 (m, 3H), 5.45 (s, 2H), 4.70-4.20 (q, 2H), 1.65-1.30 (t, 3H).
[실시예 10]Example 10
3-(2',4'-디클로로페녹시)메틸-5-아미도-1,2,4-옥사디아졸의 합성.Synthesis of 3- (2 ', 4'-dichlorophenoxy) methyl-5-amido-1,2,4-oxadiazole.
실시예 9의 (3)에서 제조한 30(2',4'-디클로로페녹시)메틸-5-에톡시카르보닐-1,2,4-옥사디아졸 0.5G(0.0016몰)을 무수 에틸 알코올 50ml에 용해시킨후, 0℃를 유지하면서 암모니아 개스를 주입시켰다. 30분동안 반응시킨후, 용매를 제거하여 융점이 153-154℃인 백색고체 0 43g을 얻었다.(수율 98%)0.5 G (0.0016 mol) of 30 (2 ', 4'-dichlorophenoxy) methyl-5-ethoxycarbonyl-1,2,4-oxadiazole prepared in (3) of Example 9 was anhydrous ethyl alcohol. After dissolving in 50 ml, ammonia gas was injected while maintaining 0 ° C. After reacting for 30 minutes, the solvent was removed to obtain 43 g of white solid 0 having a melting point of 153-154 占 폚 (yield 98%).
원소분석(C10H7C12N3O3)Elemental Analysis (C 10 H 7 C1 2 N 3 O 3 )
이론치 : C ; 41.69, H ; 2.45, N ; 14.59Theoretic value: C; 41.69, H; 2.45, N; 14.59
실측치 : C ; 41.75, H ; 2.39, N ; 14.53Found: C; 41.75, H; 2.39, N; 14.53
NMR(DMSO-d6,TMS) δ; 8.60-7.90(b,2H), 7.50-7.20(m,3H),5.50(s,2H)NMR (DMSO-d 6 , TMS) δ; 8.60-7.90 (b, 2H), 7.50-7.20 (m, 3H), 5.50 (s, 2H)
[실시예 11-12]Example 11-12
각각의 치환된 아민으로부터 실시예 10의 방법을 사용하여 제조하였다. 각 화합물들은 모두 컬럼크로마토그라피로 정제하였으며 물성 및 원소분석치는 표 1과 같다.Prepared using the method of Example 10 from each substituted amine. Each compound was purified by column chromatography and the physical and elemental analysis values are shown in Table 1.
[실시예 13]Example 13
(1) O-에톡시카르보닐(2',4'-디클로로페녹시)아세트아미드옥심의 합성.(1) Synthesis of O-ethoxycarbonyl (2 ', 4'-dichlorophenoxy) acetamide oxime.
실시예 9의 (2)에서 제조한 2,4-디클로로페녹시아세트아미드옥심 11.75g(0.05몰), 에틸클로로포름에이트 5.43g(0.05몰)과 트리에틸아민 5.06g(0.05몰)을 메틸렌클로라이드 100ml와 혼합하여 1시간동안 교반하였다. 반응액을 물로 세척한후 얻은 유기층을 무수황산나트륨으로 건조시켜 용매를 제거한후 컬럼크로마토그라피(용리체, 벤젠 에틸아세테이트=1 : 2)로 정제하여 융점 122℃의 무색결정 14.6g을 얻었다.(수율95%)11.75 g (0.05 mol) of 2,4-dichlorophenoxyacetamide oxime prepared in Example 9 (2), 5.43 g (0.05 mol) of ethylchloroformate and 5.06 g (0.05 mol) of triethylamine were 100 ml of methylene chloride. Mixed with and stirred for 1 hour. The reaction solution was washed with water, and the organic layer was dried over anhydrous sodium sulfate to remove the solvent, and then purified by column chromatography (eluent, benzene ethyl acetate = 1: 2) to give 14.6 g of colorless crystal having a melting point of 122 ° C. 95%)
NMR(CDC13, TMS) δ; 7.25-7.01(m,3H), 6.30(b,2H), 4.50(s,2H), 4.40-4.01(q,2H), 1.50-1.15(t,3H)NMR (CDC1 3 , TMS) δ; 7.25-7.01 (m, 3H), 6.30 (b, 2H), 4.50 (s, 2H), 4.40-4.01 (q, 2H), 1.50-1.15 (t, 3H)
(2) 3-(2',4'-디클로로페녹시)메틸-5-히드록시 -1,2,4-옥사디아졸의 합성.(2) Synthesis of 3- (2 ', 4'-dichlorophenoxy) methyl-5-hydroxy-1,2,4-oxadiazole.
O-에톡시카르보닐-(2',4'-디클로로페녹시)아세트아미드옥심 l2.29g(0.04몰)을 2% 수산화나트륨 수용액 100ml에 가하고 l시간동안 가연환류시켰다. 반응액을 상온으로 냉각하여 진한염산으로 pH 1-2로 산성화시킨후, 에틸아세테이트 250g로 추출하였다. 유기층을 무수황산마그네슘으로 건조시켜 용대를 게거한후 컬럼크로마토그라피(용리제, 클로로포롬 : 에틸알코올=15 : 1)로 정제하여 융점 134℃의 무색결정 5.5g을 얻었다.(수율 61%)2.29 g (0.04 mol) of O-ethoxycarbonyl- (2 ', 4'-dichlorophenoxy) acetamide oxime was added to 100 ml of an aqueous 2% sodium hydroxide solution and refluxed for l hour. The reaction solution was cooled to room temperature, acidified to pH 1-2 with concentrated hydrochloric acid, and extracted with 250 g of ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, filtered off, and purified by column chromatography (eluent, chloroform: ethyl alcohol = 15: 1) to obtain 5.5 g of colorless crystals with a melting point of 134 ° C. (Yield 61%)
원소분석(C9H6C12N2O3)Elemental Analysis (C 9 H 6 C1 2 N 2 O 3 )
이론치 : C ; 41.41, H ; 2.32, N ; 10.73Theoretic value: C; 41.41, H; 2.32, N; 10.73
실측치 : C ; 41.46, H ; 2.35, N ; 10.68Found: C; 41.46, H; 2.35, N; 10.68
NMR(CDC13, TMS)δ; 7.30-6.80(m,3H), 4.95(s,2H), 12.60(b,1H)NMR (CDC1 3 , TMS) δ; 7.30-6.80 (m, 3H), 4.95 (s, 2H), 12.60 (b, 1H)
[실시예 14]Example 14
3-(2',4'-디클로로페녹시)메틸-5-클로로-1,2,4-옥사디아졸의 합성.Synthesis of 3- (2 ', 4'-dichlorophenoxy) methyl-5-chloro-1,2,4-oxadiazole.
실시예 13의 (2)에서 제조한 3-(2',4'-디클로로페녹시)메틸-5-히드록시-1,2,4-옥사디아졸 5g(0.019몰), 포스포로스옥시트리클로라이드 19.7g(0.12몰)과 피리딘 0.49g(0.006몰)을 가하고 교반하여 10시간동안 가열환류시켰다. 반응액을 상온으로 냉각하여 얼음물 200ml에 가하고 에테르 150ml로 추출하여 유기층을 무수황산마그네슘으로 건조시켜 용매를 제거한 다음 생성된 잔류물을 컬럼크로마토그라피(용리제, 벤젠)로 정제하여 융점 56℃인 무색결정 1.61g을 얻었다.(수율 29%)5 g (0.019 mol) of 3- (2 ', 4'-dichlorophenoxy) methyl-5-hydroxy-1,2,4-oxadiazole prepared in (2) of Example 13, phosphorusoxytrichloride 19.7 g (0.12 mole) and pyridine 0.49 g (0.006 mole) were added and stirred to reflux for 10 hours. The reaction solution was cooled to room temperature, added to 200 ml of ice water, extracted with 150 ml of ether, the organic layer was dried over anhydrous magnesium sulfate, and the solvent was removed. The resulting residue was purified by column chromatography (eluent, benzene) to give a colorless color having a melting point of 56 ° C. 1.61 g of crystals were obtained. (Yield 29%)
원소분석(C9H5Cl3N2O2)Elemental Analysis (C 9 H 5 Cl 3 N 2 O 2 )
이론치 : C ; 38.67, H ; 1.80, N ; 10.02Theoretic value: C; 38.67, H; 1.80, N; 10.02
실측치 : C ; 38.71, H ; 1.78, N ; 10.09Found: C; 38.71, H; 1.78, N; 10.09
NMR(CDC13, TMS)δ; 7.50-7.01(m,3H),5.20(s,2H)NMR (CDC1 3 , TMS) δ; 7.50-7.01 (m, 3H), 5.20 (s, 2H)
[실시예 15]Example 15
(1) 에틸-(4'-히드록시) 페녹시 -2-프로피오네이트의 합성.(1) Synthesis of ethyl- (4'-hydroxy) phenoxy-2-propionate.
아세톤 300ml에 히드로퀴논 33.03g(0.3몰), 2-브로모프로피온산에틸 55g(0.3몰)과 탄산칼륨 41.46g(0.3몰)을 가하고 교반하에 24시간 가열환류시켰다. 반응액을 상온으로 냉각하여 생성된 브로모칼륨연을 제거하고 여액을 유리하여 얻은 잔류물을 에틸아세테이트 300ml로 추출하였다. 유기층을 무수황산마그네슘으로 건조시켜 용매를 게거하여 얻어진 생성물을 컬럼크로마토그라피(용리제, 벤젠, 에테르=8 : 2)로 정제하여 점성이 큰 액체 20.16g을 얻었다.(수율 32%)33.03 g (0.3 mol) of hydroquinone, 55 g (0.3 mol) of ethyl 2-bromopropionate, and 41.46 g (0.3 mol) of potassium carbonate were added to 300 ml of acetone, and it heated and refluxed for 24 hours under stirring. The reaction solution was cooled to room temperature to remove the produced bromo potassium lead, and the residue obtained by liberation of the filtrate was extracted with 300 ml of ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and the solvent was removed. The product obtained was purified by column chromatography (eluent, benzene, ether = 8: 2) to give 20.16 g of a highly viscous liquid (yield 32%).
NMR(CDC13, TMS)δ ; 6.70(s,4H), 6.01(s,1H), 4.40-4.01(q,2H), 1.40-1.l0(t,3H)NMR (CDC1 3 , TMS) δ; 6.70 (s, 4H), 6.01 (s, 1H), 4.40-4.01 (q, 2H), 1.40-1.l0 (t, 3H)
(2) 3-(2',4'-디클로로페녹시)메틸-5-클로로-1,2,4-옥사디아졸 0.6g(0.002몰)과 에틸-(4'-히드록시)페녹시-2-프로피오네이트 0.45g(0.002몰)과 탄산칼륨 0.28g(0.002몰)을 아세톤 50ml에 가하고 3시간동안 가열환류시켰다.(2) 0.6 g (0.002 mol) of 3- (2 ', 4'-dichlorophenoxy) methyl-5-chloro-1,2,4-oxadiazole and ethyl- (4'-hydroxy) phenoxy- 0.45 g (0.002 mol) of 2-propionate and 0.28 g (0.002 mol) of potassium carbonate were added to 50 ml of acetone and heated to reflux for 3 hours.
반응액을 상온으로 냉각하여 용매를 제거한 다음, 에틸아세테이트로 추출하여 유기층을 무수황산마그네슘으로 건조한 다음, 용매를 제거하여 얻은 생성물을 컬럼크로마토그라피(용리제, 벤젠)로 정제하여 0.84g의 유상물을 얻었다.(수율 93%).The reaction solution was cooled to room temperature to remove the solvent, extracted with ethyl acetate, the organic layer was dried over anhydrous magnesium sulfate, and the solvent was removed. The product obtained was purified by column chromatography (eluent, benzene) to give 0.84 g of an oily substance. (93% yield).
원소분석(C20H18C12N2O6)Elemental Analysis (C 20 H 18 C1 2 N 2 O 6 )
이론치 : C ; 53.00, H ; 4.00, N ; 6.18Theoretic value: C; 53.00, H; 4.00, N; 6.18
실측치 : C ; 53.04, H ; 3.98, N ; 6.13Found: C; 53.04, H; 3.98, N; 6.13
NMR(CDC13, TMS)δ; 7.30-6.80(m,7H), 5.01(s,2H), 4.90-4.50(q,1H), 4.40-4.10(q,2H), 180-1.60(d,3H), 1.40-1.10(t,3H)NMR (CDC1 3 , TMS) δ; 7.30-6.80 (m, 7H), 5.01 (s, 2H), 4.90-4.50 (q, 1H), 4.40-4.10 (q, 2H), 180-1.60 (d, 3H), 1.40-1.10 (t, 3H )
[실시예 16]Example 16
실시예 14에서 얻은 3-(2'4'-클로로페녹시)메틸-5-클로로-1,2,4-옥사디아졸과 α-니트로-4-콜로로페놀과 실시예 15의 (2)와 같은 방법으로 얻는다. 화합물은 컬럼크로마토그라피로 정제하였으며 물성 및 원소분석치는 표 1과 같다.(2) of Example 15 with 3- (2'4'-chlorophenoxy) methyl-5-chloro-1,2,4-oxadiazole and α-nitro-4-colophenol obtained in Example 14 Get the same way. The compound was purified by column chromatography and the physical and elemental analysis values are shown in Table 1.
[실시예 17-18]Example 17-18
페닐아세트니트릴과 4-클로로벤조니트릴로부터 실시예 13의 (2)와 같은 조건과 방법으로 3-벤질-5-히드록시-1,2,4-옥사디아졸과 3-(4'-클로로페닐)-5-히드록시-1,2,4-옥사디아졸을 합성한후 실시예 14와 같은 조건과 방법으로 3-벤질-5-클로로-1,2,4-옥사디아졸과 3-(4'-클로로페닐)-5-클로로-1,2,4-옥사디아졸올 제조하였다. 이 생성물들을 실시예 15의 (2)와 같은 조건과 방법으로 반응시켜 화합물을 제조하였다. 각 화합물들은 모두 컬럼크로마토그라피로 정제하였으며 물성 및 원소분석치는 표 1과 같다.3-benzyl-5-hydroxy-1,2,4-oxadiazole and 3- (4'-chlorophenyl) from phenylacetnitrile and 4-chlorobenzonitrile under the same conditions and methods as in Example 13 (2). ) -5-hydroxy-1,2,4-oxadiazole was synthesized, and 3-benzyl-5-chloro-1,2,4-oxadiazole and 3- ( 4'-chlorophenyl) -5-chloro-1,2,4-oxadiazolol was prepared. The products were reacted under the same conditions and methods as in Example 15 (2) to prepare a compound. Each compound was purified by column chromatography and the physical and elemental analysis values are shown in Table 1.
[실시예 19-21]Example 19-21
실시예 14에서 연은 3-(2',4'-디클로로페녹시)에틸-5-클로로-1,2,4-옥사디아졸과 실시예 14와 같은 방법으로 얻은 3-벤질-5-클로로-1,2,4-옥사디아졸과 3-(4'-클로로페닐)-5-클로로-1,2,4-옥사디아졸을 치환기를 갖는 페놀과 실시예 15의 (2)와 같은 방법으로 반응시켜 화합물을 제조하였다. 각 화합물들은 모두 컬럼크로마토그라피로 정제하였으며 물성 및 원소분석치는 표 1과 같다.In Example 14, the lead was 3- (2 ', 4'-dichlorophenoxy) ethyl-5-chloro-1,2,4-oxadiazole and 3-benzyl-5-chloro obtained in the same manner as in Example 14. The method of Example 15 (2) with phenol having a substituent of -1,2,4-oxadiazole and 3- (4'-chlorophenyl) -5-chloro-1,2,4-oxadiazole The reaction was carried out to prepare a compound. Each compound was purified by column chromatography and the physical and elemental analysis values are shown in Table 1.
[실시예 22]Example 22
3-(2',4'-디클로로페녹시)메틸-5-디에틸포스포닐-1,2,4-옥사디아졸의 합성.Synthesis of 3- (2 ', 4'-dichlorophenoxy) methyl-5-diethylphosphonyl-1,2,4-oxadiazole.
건조된 톨루엔 5ml에 실시예 14에서 얻은 3-(2',4'-디클로로페녹시)메틸-5-클로로-1,2,4-옥사디아졸 0.14g(0.0005)몰과 드리에틸포스페이트 0.2g(0.00118몰)을 가하고 교반하여 12시간 가열환류시켰다. 반응액을 몰 50m1에 혼합하여 에틸아세테이트 20ml로 추출한후 무수황산마그네슘으로 건조시키고 용매를 제거하여 얻은 유상의 생성물을 컬럼크로마토그라피(용리제, 벤젠 에테르=1 : 1)로 정제하여 무색의 액체인 3-(2',4'-디클로로페녹시)메틸-5-디에틸포스포닐-1,2,4-옥사디아졸 0.165g을 얻었다.(수율 87%)0.14 g (0.0005) mole of 3- (2 ', 4'-dichlorophenoxy) methyl-5-chloro-1,2,4-oxadiazole obtained in Example 14 in 0.2 ml of dried toluene and 0.2 g of driethylphosphate (0.00118 mol) was added and stirred to reflux for 12 hours. The reaction mixture was mixed with 50 ml of mole, extracted with 20 ml of ethyl acetate, dried over anhydrous magnesium sulfate, and the solvent was removed. The oily product was purified by column chromatography (eluent, benzene ether = 1: 1) to obtain a colorless liquid. 0.165 g of 3- (2 ', 4'-dichlorophenoxy) methyl-5-diethylphosphonyl-1,2,4-oxadiazole was obtained (yield 87%).
원소분석(C13H15C12N2O5P)Elemental Analysis (C 13 H 15 C1 2 N 2 O 5 P)
이론치 : C ; 40.90, H ; 3.97, N ; 7.35Theoretic value: C; 40.90, H; 3.97, N; 7.35
실측치 : C ; 40.95, H ; 3.99, N ; 7.40Found: C; 40.95, H; 3.99, N; 7.40
NMR(CDC13, TMS)δ ; 7.30-6.90(m,3H), 5.20(s,2H), 4.50-4.01(m,4H), 1.50-1.10(m,6H)NMR (CDC1 3 , TMS) δ; 7.30-6.90 (m, 3H), 5.20 (s, 2H), 4.50-4.01 (m, 4H), 1.50-1.10 (m, 6H)
[실시예 23]Example 23
(1) n-프로피오아미드옥심의 합성.(1) Synthesis of n-propioamide oxime.
히드록실아민염산염 6.95g(0.1몰)과 탄산나트륨 5.3g(0.05몰)을 몰 50ml에 용해시키고 n-프로피오니트릴 5.5g(0.1몰)을 에틸알코올 50ml에 용해하여 혼합한 다음, 교반하에 가연하여 6시간 환류시켰다. 반응액을 농축한후, 잔류물을 에틸아세테이트 100ml로 추출하여 얻은 유기층을 무수황산마그네슘으로 건조시켜 용매를 제거하여 담청색의 점성이 큰 액체인 n-프로피오아미드옥심 4.93g을 얻었다.(수율 55%)6.95 g (0.1 mol) of hydroxylamine hydrochloride and 5.3 g (0.05 mol) of sodium carbonate were dissolved in 50 ml of mole, and 5.5 g (0.1 mol) of n-propionitrile was dissolved in 50 ml of ethyl alcohol, mixed, and then smoked under stirring. It was refluxed for 6 hours. The reaction solution was concentrated, and the residue was extracted with 100 ml of ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and the solvent was removed to obtain 4.93 g of n-propioamide oxime, a light blue viscous liquid (yield 55). %)
(2) O-클로로아세틸-n-프로피오아미드옥심의 합성.(2) Synthesis of O-chloroacetyl-n-propioamide oxime.
(1)에서 제조한 n-프로피오아미드옥심 4.4g(0.05몰)을 디옥산 50ml에 가하고 교반하였다. (1)과 같은 조건과 방법으로 반응시켜 O-클로로아세틸-n-프로피오아이드옥심 7.lg을 얻었다.(수율86%)4.4 g (0.05 mol) of n-propioamide oxime prepared in (1) was added to 50 ml of dioxane and stirred. The reaction was carried out under the same conditions and methods as in (1), to obtain O-chloroacetyl-n-propioid oxime 7.lg. (Yield 86%)
(3) 3-에틸-5-클로로메틸-1,2,4-옥사디아졸의 합성.(3) Synthesis of 3-ethyl-5-chloromethyl-1,2,4-oxadiazole.
(2)에서 제조한 O-클로로아세틸-n-프로피오아미드옥심 4.1lg(0.025몰)을 디옥산 50ml에 가하고 교반하였다. 반응액에 플루오르화붕소에테르 0.3g을 가하고 가열하여 6시간 환류시켰다. 반응종료후 반응액을 농축하여 얻은 잔류물을 에틸아세테이트 100lml로 건조시켜 용매를 제거하였다. 생성물올 컬럼크로마토그라피(용리제, 벤젠 : 에테르=8 : 2)로 정제하여 무색의 유상물 3.24g을 얻었다.(수율 72%)4.1 lg (0.025 mol) of O-chloroacetyl-n-propioamide oxime prepared in (2) was added to 50 ml of dioxane and stirred. 0.3 g of boron fluoride ether was added to the reaction solution and heated to reflux for 6 hours. After completion of the reaction, the reaction solution was concentrated, and the residue was dried over 100 ml of ethyl acetate to remove the solvent. The product was purified by column chromatography (eluent, benzene: ether = 8: 2) to obtain 3.24 g of a colorless oil. (Yield 72%)
NMR(CDC13, TMS)δ ; 4.80(s,2H), 2.8-2.5(q,2H), 1.30-1.01(t,3H)NMR (CDC1 3 , TMS) δ; 4.80 (s, 2H), 2.8-2.5 (q, 2H), 1.30-1.01 (t, 3H)
(4) 3-에틸-5-[4'-(1"-에톡시카르보닐-1"-메틸)메톡시]페녹시메틸-1,2,4-옥사디아졸의 합성(4) Synthesis of 3-ethyl-5- [4 '-(1 "-ethoxycarbonyl-1" -methyl) methoxy] phenoxymethyl-1,2,4-oxadiazole
(3)에서 제조한 3-에틸-5-클로로메틸-1,2,4-옥사디아졸 0.73g(0.005몰)과 실시예 15의 (1)에서 제조한 에틸-(4'-히드록시)페녹시 -2-프로피오네이트 1.05g(0.005몰)과 탄산칼륨 0.35g(0.005몰)을 아세톤50ml에 가하고 24시간 가열환류하였다. 반응액을 상온으로 냉각하여 용매를 제거한 다음, 에틸아세테이트 50ml로 추출하여 유기층을 무수황산마그네슘으로 건조시켜 용매를 제거하였다. 잔류물을 컬럼크로마토그라피(용리제, 벤젠 : 에테르=8 : 2)로 정제하여 유상물 1.3g을 얻었다.(수율 82%)0.73 g (0.005 mol) of 3-ethyl-5-chloromethyl-1,2,4-oxadiazole prepared in (3) and ethyl- (4'-hydroxy) prepared in (1) of Example 15 1.05 g (0.005 mol) of phenoxy-2-propionate and 0.35 g (0.005 mol) of potassium carbonate were added to 50 ml of acetone and heated to reflux for 24 hours. The reaction solution was cooled to room temperature to remove the solvent, extracted with 50 ml of ethyl acetate and the organic layer was dried over anhydrous magnesium sulfate to remove the solvent. The residue was purified by column chromatography (eluent, benzene: ether = 8: 2) to obtain 1.3 g of an oil (yield 82%).
원소분석(C16H20N2O5)Elemental Analysis (C 16 H 20 N 2 O 5 )
이론치 : C ; 59.99, H ; 6.29, N ; 8.74Theoretic value: C; 59.99, H; 6.29, N; 8.74
실측치 : C ; 60.04, H ; 6.30, N ; 8.70Found: C; 60.04, H; 6.30, N; 8.70
NMR(CDC13, TMS)δ ; 6.80(s,4H), 5.05(s,2H), 4.80-4.40(q-1H), 4.30-3.90(q,2H), 2.80-2.50(m,2H), 1.50-1.01(m,9H).NMR (CDC1 3 , TMS) δ; 6.80 (s, 4H), 5.05 (s, 2H), 4.80-4.40 (q-1H), 4.30-3.90 (q, 2H), 2.80-2.50 (m, 2H), 1.50-1.01 (m, 9H).
[실시예 24-26]Example 24-26
2-클로로-6-플루오로벤조니트릴, 페닐아세트니트릴, 2,4-디클로로페녹시아세트니트릴을 사용하여 실시예 22와 같은 방법으로 제조한 5-클로로메틸-1,2,4-옥사디아졸 유도체를 실시예 15의 (1)에서 제조한 에틸-(4'-히드록시)페녹시-2-프로피오네이트와 실시예 22의 (4)와 같은 방법으로 제조하였다. 각 화합물을 컬럼크로마토그라피로 정제하였으며 물성 및 원소분석치는 표 1과 같다5-Chloromethyl-1,2,4-oxadiazole prepared in the same manner as in Example 22 using 2-chloro-6-fluorobenzonitrile, phenylacetnitrile, and 2,4-dichlorophenoxysetnitrile The derivative was prepared in the same manner as in Example 22 (4) with ethyl- (4'-hydroxy) phenoxy-2-propionate prepared in Example (1). Each compound was purified by column chromatography, and the physical and elemental analysis are shown in Table 1.
[실시예 27]Example 27
3-(2',4'-디클로로페녹시)메틸-5-(N',N'-디에틸카르바모일티오)메틸-1,2,4-옥사디아졸의 합성.Synthesis of 3- (2 ', 4'-dichlorophenoxy) methyl-5- (N', N'-diethylcarbamoylthio) methyl-1,2,4-oxadiazole.
톨루엔 50ml에 디에틸아민 0.73g(0.01몰)을 가하고 0℃로 냉각하여 카르보닐실파이드 개스 3g(0.05몰)을 주입시킨 다음, 30분간 교반하였다. 반응액에 실시예 26에서 제조한 3-(2',4'-디클로로페녹시)메틸-5-클보로메틸-1,2,4-옥사디아졸 1.4g(0.005몰)을 가하고 70℃로 가온하여 3시간동안 교반하였다. 반응액을 상온으로 냉각하여 물 50ml로 세척하고 유기층을 무수황산마그네슘으로 건조시켜 용매를 제거한 다음, 얻어진 잔유물을 컬럼크로마토그라피(용리제, 벤젠 : 에테르=1 : 1)로 정제하여 1.4g을 얻었다.0.73 g (0.01 mol) of diethylamine was added to 50 ml of toluene, cooled to 0 ° C, and charged with 3 g (0.05 mol) of carbonyl silicide gas, followed by stirring for 30 minutes. 1.4 g (0.005 mol) of 3- (2 ', 4'-dichlorophenoxy) methyl-5-cloboromethyl-1,2,4-oxadiazole prepared in Example 26 was added to the reaction solution at 70 ° C. Warm and stir for 3 hours. The reaction solution was cooled to room temperature, washed with 50 ml of water, the organic layer was dried over anhydrous magnesium sulfate, and the solvent was removed. The resulting residue was purified by column chromatography (eluent, benzene: ether = 1: 1) to obtain 1.4 g. .
원소분석(C15H17C12N3O3S)Elemental Analysis (C 15 H 17 C 12 N 3 O 3 S)
이론치 : C ; 46.16, H ; 4.39, N ; 10.77Theoretic value: C; 46.16, H; 4.39, N; 10.77
실측치 : C ; 46.11, H ; 4.43, N ; 10.80Found: C; 46.11, H; 4.43, N; 10.80
NMR(CDC13, TMS)δ; 7.30-6.80(m,3H), 5.20(s,2H), 4.30(s,2H), 3.60-3.20(q,4H), 1.30-1.01(t,6H)NMR (CDC1 3 , TMS) δ; 7.30-6.80 (m, 3H), 5.20 (s, 2H), 4.30 (s, 2H), 3.60-3.20 (q, 4H), 1.30-1.01 (t, 6H)
[실시예 28-29]Example 28-29
실시예 22의 (3)과 같은 방법으로 제조한 3-벤절-5-클로로메틸-1,2,4-옥사디아졸과 3-(2'-클로로-6'-플루오르)페닐-5-클로로메틸-1,2,4-옥사디아졸을 실시예 27과 같은 방법으로 제조하였다. 각 화합물들을 컬럼크로마토그라피로 정제하였으며 물성 및 원소분석치는 표 1과 같다.3-Benzal-5-chloromethyl-1,2,4-oxadiazole and 3- (2'-chloro-6'-fluoro) phenyl-5-chloro prepared in the same manner as in Example 22 (3) Methyl-1,2,4-oxadiazole was prepared in the same manner as in Example 27. Each compound was purified by column chromatography and the physical and elemental analysis values are shown in Table 1.
[실시예 30]Example 30
(1) [4'-(1"-에톡시카르보닐-1"-메틸)메톡시]페녹시아미드옥심의 합성.(1) Synthesis of [4 '-(1 "-ethoxycarbonyl-1" -methyl) methoxy] phenoxyamide oxime.
실시예 15의 (1)에서 제조한 에틸-(4'-히드록시)페녹시-2-프로피오네이트 3.2g(0.015몰)과 시아노브로마이드 2g(0.02몰)을 0℃에서 서서히 반응시킨후 1시간동안 0℃에서 잘 교반하였다. 히드록시 아민염산염 1.04g(0.015몰)과 탄산나트륨 1.6g(0.015몰)을 물 20ml에 녹인 용액을 반응물에 넣은후, 3시간동안 30-40℃에서 반응시켰다. 반응물올 에틸아세테이트로 추출한 다음, 용매를 제거하여 백색고체 3.01g을 얻었다.(수율 75.3%)3.2 g (0.015 mol) of ethyl- (4'-hydroxy) phenoxy-2-propionate prepared in Example 15 (1) and 2 g (0.02 mol) of cyanobromide were slowly reacted at 0 ° C. Stir well at 0 ° C. for 1 h. A solution of 1.04 g (0.015 mol) of hydroxy amine hydrochloride and 1.6 g (0.015 mol) of sodium carbonate dissolved in 20 ml of water was added to the reaction, followed by reaction at 30-40 ° C. for 3 hours. The reaction product was extracted with ethyl acetate and the solvent was removed to yield 3.01 g of a white solid. (Yield 75.3%)
(2) 3-[4'-(1"-에톡시카르보닐-1"-메틸)메톡시]페녹시아미드옥심의 합성.(2) Synthesis of 3- [4 '-(1 "-ethoxycarbonyl-1" -methyl) methoxy] phenoxyamide oxime.
실시예 15의 (1)에서 제조한 에틸-(4'-히드록시)페녹시-2-프로피오네이트 3.2g(0.015몰)과 시아노브로마이드 2g(0.02몰)을 0℃에서 서서히 반응시킨후 1시간동안 0℃에서 잘 교반하였다. 히드록시 아민염산염 1.04g(0.015몰)과 탄산나트륨 1.6g(0.015몰)을 물 20ml에 녹인 용액을 반응물에 넣은후, 3시간동안 30-40℃에서 반응시켰다. 반응물을 에틸아세테이트로 추출한 다음, 용매를 제거하여 백색교체 3.01g을 얻었다.(수율 75.3%)3.2 g (0.015 mol) of ethyl- (4'-hydroxy) phenoxy-2-propionate prepared in Example 15 (1) and 2 g (0.02 mol) of cyanobromide were slowly reacted at 0 ° C. Stir well at 0 ° C. for 1 h. A solution of 1.04 g (0.015 mol) of hydroxy amine hydrochloride and 1.6 g (0.015 mol) of sodium carbonate dissolved in 20 ml of water was added to the reaction, followed by reaction at 30-40 ° C. for 3 hours. The reaction was extracted with ethyl acetate, and then the solvent was removed to obtain 3.01 g of a white replacement. (Yield 75.3%)
(2) 3-[4'-(1"-에톡시카르보닐-1"-메틸)메톡시]페녹시-5-(2",4-디클로로페녹시)메틸-1,2,4-옥사아졸의 합성.(2) 3- [4 '-(1 "-ethoxycarbonyl-1" -methyl) methoxy] phenoxy-5- (2 ", 4-dichlorophenoxy) methyl-1,2,4-oxa Synthesis of azoles.
(1)에서 제조한 [4'-(에톡시카르보닐-1"-메틸)메톡시]페녹시아미드옥심 0.67g(0.0025몰)과 (2',4'-디클로로페녹시)아세틸클로라이드 0.6g(0.0025몰)을 디옥산 50ml에 넣은 다음, 트리플루오로 붕소 에테르 0.2ml를 넣고 6시간 가열환류시켰다. 용매를 제거한후 컬럼크로마토그라피(용리제, 벤젠 : 에테르=8 : 2)로 정제하여 융점이 43℃인 노란결정 0.7g을 얻었다.(수율 62%)0.67 g (0.0025 mol) of [4 '-(ethoxycarbonyl-1 "-methyl) methoxy] phenoxyamide oxime prepared in (1) and 0.6 g of (2', 4'-dichlorophenoxy) acetyl chloride (0.0025 mol) was added to 50 ml of dioxane, followed by 0.2 ml of trifluoroboron ether, and refluxed for 6 hours.The solvent was removed, and the residue was purified by column chromatography (eluent, benzene: ether = 8: 2) to form a melting point. 0.7g of this yellow crystals which are 43 degreeC were obtained. (Yield 62%)
원소분석(C20H18C12N2O6)Elemental Analysis (C 20 H 18 C1 2 N 2 O 6 )
이론치 : C ; 53.00, H ; 4.00, N ; 6.18Theoretic value: C; 53.00, H; 4.00, N; 6.18
실속치 : C ; 53.05, H ; 4.0l, N ; 6.14Stall: C; 53.05, H; 4.01, N; 6.14
R(CDCl3, TMS)δ ; 7.40-6.80(m,7H),5.25(s,2H),4.75(q,2H),4.25(q,2H),1.65(d,3H),1.30(t,3H)R (CDCl 3 , TMS) δ; 7.40-6.80 (m, 7H), 5.25 (s, 2H), 4.75 (q, 2H), 4.25 (q, 2H), 1.65 (d, 3H), 1.30 (t, 3H)
[실시예 31]Example 31
3-(N'.N'-디에틸카르바모일티오)메틸-5-(2',4'-디클로로페녹시)메틸-1,2,4-옥사디아졸의 합성.Synthesis of 3- (N'.N'-diethylcarbamoylthio) methyl-5- (2 ', 4'-dichlorophenoxy) methyl-1,2,4-oxadiazole.
건조된 톨루엔 50ml에 디에틸아민 0.29g(0.004몰)을 가하고 0℃로 냉각하여 카르보닐설파이드 개스 1.2g(0.02몰)을 주입시킨 다음 30분간 교반하였다. 반응액에 특허출원 제 1966호 실시예 7에서 제조한 3-클로로메틸-5-(2',4'-디클로로페녹시)메틸-l,2,4-옥사디아졸 0.6g(0.002몰)을 가하고 60℃로 가온하여 3시간동안 교반하였다. 반응액을 상온으로 냉각하여 몰 25ml로 세척하고 유기층을 무수황산마그네슘으로 건조시켜 용매를 제거한 다음 얻어진 잔류물을 컬럼크로마토그라피(용리제, 벤젠 : 에테르=8 : 2)로 정제하여 0.78g을 얻었다.(수율 50%)0.29 g (0.004 mole) of diethylamine was added to 50 ml of dried toluene, cooled to 0 ° C., 1.2 g (0.02 mole) of carbonylsulfide gas was added thereto, followed by stirring for 30 minutes. 0.6 g (0.002 mol) of 3-chloromethyl-5- (2 ', 4'-dichlorophenoxy) methyl-l, 2,4-oxadiazole prepared in Example 7 of Patent Application No. 1966 was added to the reaction solution. Warmed to 60 ° C. and stirred for 3 h. The reaction solution was cooled to room temperature, washed with 25 ml of mole, the organic layer was dried over anhydrous magnesium sulfate, and the solvent was removed. The resulting residue was purified by column chromatography (eluent, benzene: ether = 8: 2) to obtain 0.78 g. (50% yield)
원소분석(C15Hl7C12N3O3S)Elemental Analysis (C 15 H l7 C1 2 N 3 O 3 S)
이론치 : C ; 46.16, H ; 4.39, N ; 10.77Theoretic value: C; 46.16, H; 4.39, N; 10.77
실측치 : C ; 46.13, H ; 4.40, N ; 10.79Found: C; 46.13, H; 4.40, N; 10.79
NMR(CDC13, TMS)δ; 7.30-6.85(m,3H), 5.25(s,2H), 4.15(s,2H), 3.28(q,4H), 1.05(t,6H)NMR (CDC1 3 , TMS) δ; 7.30-6.85 (m, 3H), 5.25 (s, 2H), 4.15 (s, 2H), 3.28 (q, 4H), 1.05 (t, 6H)
본 발명의 화합물에 대한 제초활성 시험은 아래에 기술한 방법에 의하여 실시하였다.Herbicidal activity tests on the compounds of the present invention were carried out by the methods described below.
(제초활성시험)(Herbicidal activity test)
1. 밭 및 건답조건에서의 제초활성시험1. Herbicide activity test in field and dry condition
적당량의 비료가 혼합된 사질양토를 살균한 다음 시험용 폿트(밭조건 : 34cm2, 건답조건 : 115cm*)에 담는다. 그후 토마토, 콩, 옥수수, 오챠드그라스, 비름, 강아지풀(또는 바랭이), 여뀌, 참소리쟁이, 자귀풀, 메꽃 등의 종자 또는 지하경을 밭조건의 두 폿트에 벼, 피, 알방동산이, 사마귀풀 등의 종자를 건답조건의한 폿트에 각각 파종한 다음 곱게 친 흙으로 복토한후 온실에 둔다. 4kg/ha수준의 시험화합물(밭조건 : 14mg/pot, 건답조건 : 4mg/pot)을 용매(아세톤, 에탄올 등)에 녹인 다음 비이온성 계면활성제(Tween-20)가 첨가된 물에 각각 1 : 1이 되도록 희석하여 밭조건의 경우 폿트당 14ml건답조건의 경우 폿트당 4ml살포한다. 이때 발아전 토양처리(pre)는 파종후 1일째, 발아후 경엽처리(post)는 파종후 8-12일째에 조제된 약제를 처리한다. 약제를 처리한후, 온실내에서 2-3주간 키운 다음 이들의 제초효과를 형태 및 생리학적 관찰 근거에 의해 달관 조사한다. 즉 무방제의 경우를 0, 완전방제의 경우를 100으로 하여 제초활성 정도를 평가하는데 70이상의 등급을 가지면 실제적으로 그 식물에 대하여 제초효과가 있는 것으로 인정한다. 밭 및 건답조건에서 상기 화합물들의 제초활성 시험결과는 표 2와 같다.Sterilize the sandy loam mixed with an appropriate amount of fertilizer and place it in a test pot (field condition: 34cm 2 , dry condition: 115cm * ). Seeds or underground seeds of tomato, soybean, corn, orchardgrass, amaranth, ragweed (or bergamot), silkworm, squirrel, silkworm, buckwheat, etc. Seeds are sown in pots under dry conditions, covered with finely ground soil and placed in a greenhouse. 4 kg / ha level test compound (field condition: 14 mg / pot, dry condition: 4 mg / pot) was dissolved in a solvent (acetone, ethanol, etc.) and then added to a nonionic surfactant (Tween-20) in water 1: Dilute to 1 and spray 14 ml per pot for field conditions and 4 ml per pot for dry conditions. At this time, the pretreatment soil treatment (pre) is treated on the 1st day after sowing, the post-germination foliage treatment (post) 8-8 days after sowing. After treatment with the drugs, they are grown in a greenhouse for 2-3 weeks and their herbicidal effects are examined by morphology and physiological observations. In other words, if the degree of herbicidal activity is evaluated as 0 for no control and 100 for complete control, the degree of herbicidal activity is recognized as having a herbicidal effect on the plant. Herbicide activity test results of the compounds in the field and dry conditions are shown in Table 2.
2. 담수조건에서의 논 제초활성시험2. Paddy herbicide activity test under freshwater conditions
60cm2(PRS, 1차) 또는 140cm2(2차)원형 폿트의 바닥에 비료를 소량놓고 곤죽상태의 멸균된 논흙은 5cm깊이로 담는다. 논피, 알방동산이, 사마귀풀, 물달개비, 마디꽃, 여뀌바늘, 올챙이고랭이, 밭뚝외풀 등의 종자와 다년생 영양체를 토양표층에 혼입하고 미리 육모해둔 벼의 유묘(2-3엽기)를 폿트망 1본씩 2cm깊이로 심는다. 이식한후 2cm깊이로 단수하여 1일간 둔 다음 밭조건에서와 같이 조제된 약제를 골고루 점적 처리한다(4kg/ha 수준의 경우 폿트당 4ml). 약제 처리후 2주째에 밭조건과 동일한 조사기준에 의하여 제초활성을 조사한다. 담수조건에서 상기 화합물들의 제초활성시험 결과는 표 3과 같다.A small amount of fertilizer is placed on the bottom of a 60 cm 2 (PRS, 1st) or 140 cm 2 (2nd) round pot, and the sterilized sterilized soil is 5 cm deep. Seeds and perennial nutrients such as paddy fields, eggplants, mantis grass, mantis grass, knotweed flowers, needles, tadpoles, and turmeric on the surface of the soil are added to the surface of the seedlings (2-3 leaves). Plant each pot net 2cm deep. After transplanting, cut to 2cm depth and leave for 1 day, and then drip the prepared medicine as in field condition (4ml / pot for 4kg / ha level). At 2 weeks after drug treatment, herbicidal activity was examined according to the same survey criteria as field conditions. The herbicidal activity test results of the compounds under freshwater conditions are shown in Table 3.
이상과 같은 제초활성 시험에 사용된 식물체의 약어는 표 4에 나타냈으며, 제초효력 검정기준은 표 5와 같다.The abbreviations of the plants used in the herbicidal activity test described above are shown in Table 4, and the herbicidal efficacy assay criteria are shown in Table 5.
Claims (9)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019880008435A KR900006555B1 (en) | 1988-07-07 | 1988-07-07 | 1,2,4-oxadiazole derivatives and preparation method thereof |
| JP1158449A JPH0826009B2 (en) | 1988-07-07 | 1989-06-22 | Novel 1,2,4-oxadiazole derivatives useful as selective herbicides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019880008435A KR900006555B1 (en) | 1988-07-07 | 1988-07-07 | 1,2,4-oxadiazole derivatives and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR900001664A KR900001664A (en) | 1990-02-27 |
| KR900006555B1 true KR900006555B1 (en) | 1990-09-13 |
Family
ID=19275910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019880008435A Expired KR900006555B1 (en) | 1988-07-07 | 1988-07-07 | 1,2,4-oxadiazole derivatives and preparation method thereof |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPH0826009B2 (en) |
| KR (1) | KR900006555B1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4306962A1 (en) * | 1993-03-05 | 1994-09-08 | Bayer Ag | Oxadiazolecarboxylic acid derivatives |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62267274A (en) * | 1986-05-16 | 1987-11-19 | Aguro Kanesho Kk | 1,2,4-oxadiazole derivative |
-
1988
- 1988-07-07 KR KR1019880008435A patent/KR900006555B1/en not_active Expired
-
1989
- 1989-06-22 JP JP1158449A patent/JPH0826009B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR900001664A (en) | 1990-02-27 |
| JPH0248571A (en) | 1990-02-19 |
| JPH0826009B2 (en) | 1996-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS59212472A (en) | 4,5,6,7-tetrahydro-2h-isoindole-1,3-dione derivative, its production and herbicide containing the same as active constituent | |
| KR0147844B1 (en) | Cyclic Amide Derivatives and Herbicides | |
| JP3047447B2 (en) | Pyrazole derivative, method for producing the same, and herbicide containing the same as an active ingredient | |
| KR910001238B1 (en) | O-acylamide oxime derivative | |
| KR900006555B1 (en) | 1,2,4-oxadiazole derivatives and preparation method thereof | |
| KR0174026B1 (en) | Triazole compounds | |
| JP2503547B2 (en) | Carbamoyltriazole derivative, its production method and herbicide containing it as an active ingredient | |
| JPH0231067B2 (en) | ||
| JP2810544B2 (en) | N-acyl-N-phenyltetrahydrophthalamic acid derivative, method for producing the same, and herbicide containing the same as an active ingredient | |
| KR0131528B1 (en) | Novel pyrimidine derivatives, their preparation and their use as herbicides | |
| KR900003272B1 (en) | 1,2,4-oxadiazole derivatives with aromatic substituents | |
| KR900003271B1 (en) | Substituted 1,2,4-oxadiazole derivatives and preparation method thereof | |
| KR920005413B1 (en) | 1,2,4-oxadiazole derivative substituted 3-phenoxymethy group | |
| KR910002876B1 (en) | 1,2,4-oxadiazole derivatives with 2,4-d substitutes and process for the preparation of its | |
| KR930011280B1 (en) | 1,2,4-oxadiazole oxyacetamide derivative | |
| KR900003273B1 (en) | 1,2,4-oxadiazine derivatives | |
| KR0174374B1 (en) | Herbicidal pyrimidine compound having benzophenoneoxime ester and process for preparation thereof | |
| KR910002875B1 (en) | 1,2,4-oxadiazole derivatives having 2,4-D substituents and preparation methods | |
| JP2809481B2 (en) | 2-Alkoxycarbonyl-3-pyridinecarboxylic acid derivatives, their production and herbicides | |
| KR100345852B1 (en) | 1-benzyl-4,5-dicarbonyl-1,2,3-triazole derivatives and preparation process thereof | |
| KR0174375B1 (en) | Herbicidal pyrimidine derivatives having tricyclic ketone oxime ester and process for preparation thereof | |
| KR840001556B1 (en) | Method for preparing β-naphthoxypropionic acid amide derivative | |
| KR100454099B1 (en) | Herbicidal 9-(5-isoxazolinemethoxyphenyl)imino-8-thia-1,6-diazabicyclo[4.3.0]nonan-7-one derivatines | |
| JPS61221170A (en) | Trifluoromethanesulfonylamide derivative and herbicide containing said derivative as active component | |
| KR0183540B1 (en) | 1,2,4-oxadiazole-5-one derivatives and preparation methods thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| G160 | Decision to publish patent application | ||
| PG1605 | Publication of application before grant of patent |
St.27 status event code: A-2-2-Q10-Q13-nap-PG1605 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 7 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 8 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 9 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 10 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 11 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| FPAY | Annual fee payment |
Payment date: 20010605 Year of fee payment: 12 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 12 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20020914 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20020914 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-4-4-P10-P22-nap-X000 |